Matt has extensive experience in public and private financings, buy-side and sell-side transactions and fairness opinions in the Healthcare sector. Before joining us in 2007, he worked in First Albany's Healthcare Investment Banking Group. Matt was instrumental in building their Healthcare franchise into one of the most active boutique investment banks focused on the Life Sciences sector and was head of their West Coast Investment Banking efforts. Before this, he worked in the mergers and acquisitions group at Robertson Stephens, focusing on the Life Sciences practice and also worked at PaineWebber. Matt graduated with a Master of Business Administration from the University of Virginia and earned a BA from St. Lawrence University.
Selected Transactions
-
TransMedics
Financial Advisor (Buy side)
-
US$127m
Paragon 28, Inc.
Lead Manager (Follow-On Offering)
-
Biorez, Inc.
Financial Advisor (Sell side)
-
N/a
OrthogenRx, Inc.
Financial Advisor (Sell side)
-
US$70m
Lucid Diagnostics Inc.
Joint Bookrunner (IPO)
-
US$143m
Paragon 28, Inc.
Lead Manager (IPO)
-
US$872m
Vicarious Surgical Inc.
Financial/Capital Markets Advisor (SPAC)
-
US$145m
CVRx
Lead Manager (IPO)
-
US$60m
obp Medical Corporation
Financial Advisor to obp Medical Corporation on sale of assets to CooperSurgical, Inc
